Cargando…
Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995568/ https://www.ncbi.nlm.nih.gov/pubmed/33765996 http://dx.doi.org/10.1186/s12935-021-01876-1 |
_version_ | 1783669943482449920 |
---|---|
author | Chen, Jihui Wang, Zhipeng Gao, Shouhong Wu, Kejin Bai, Fang Zhang, Qiqiang Wang, Hongyu Ye, Qin Xu, Fengjing Sun, Hong Lu, Yunshu Liu, Yan |
author_facet | Chen, Jihui Wang, Zhipeng Gao, Shouhong Wu, Kejin Bai, Fang Zhang, Qiqiang Wang, Hongyu Ye, Qin Xu, Fengjing Sun, Hong Lu, Yunshu Liu, Yan |
author_sort | Chen, Jihui |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7995568 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79955682021-03-26 Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer Chen, Jihui Wang, Zhipeng Gao, Shouhong Wu, Kejin Bai, Fang Zhang, Qiqiang Wang, Hongyu Ye, Qin Xu, Fengjing Sun, Hong Lu, Yunshu Liu, Yan Cancer Cell Int Correction BioMed Central 2021-03-25 /pmc/articles/PMC7995568/ /pubmed/33765996 http://dx.doi.org/10.1186/s12935-021-01876-1 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Correction Chen, Jihui Wang, Zhipeng Gao, Shouhong Wu, Kejin Bai, Fang Zhang, Qiqiang Wang, Hongyu Ye, Qin Xu, Fengjing Sun, Hong Lu, Yunshu Liu, Yan Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer |
title | Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer |
title_full | Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer |
title_fullStr | Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer |
title_full_unstemmed | Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer |
title_short | Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer |
title_sort | correction to: human drug efflux transporter abcc5 confers acquired resistance to pemetrexed in breast cancer |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995568/ https://www.ncbi.nlm.nih.gov/pubmed/33765996 http://dx.doi.org/10.1186/s12935-021-01876-1 |
work_keys_str_mv | AT chenjihui correctiontohumandrugeffluxtransporterabcc5confersacquiredresistancetopemetrexedinbreastcancer AT wangzhipeng correctiontohumandrugeffluxtransporterabcc5confersacquiredresistancetopemetrexedinbreastcancer AT gaoshouhong correctiontohumandrugeffluxtransporterabcc5confersacquiredresistancetopemetrexedinbreastcancer AT wukejin correctiontohumandrugeffluxtransporterabcc5confersacquiredresistancetopemetrexedinbreastcancer AT baifang correctiontohumandrugeffluxtransporterabcc5confersacquiredresistancetopemetrexedinbreastcancer AT zhangqiqiang correctiontohumandrugeffluxtransporterabcc5confersacquiredresistancetopemetrexedinbreastcancer AT wanghongyu correctiontohumandrugeffluxtransporterabcc5confersacquiredresistancetopemetrexedinbreastcancer AT yeqin correctiontohumandrugeffluxtransporterabcc5confersacquiredresistancetopemetrexedinbreastcancer AT xufengjing correctiontohumandrugeffluxtransporterabcc5confersacquiredresistancetopemetrexedinbreastcancer AT sunhong correctiontohumandrugeffluxtransporterabcc5confersacquiredresistancetopemetrexedinbreastcancer AT luyunshu correctiontohumandrugeffluxtransporterabcc5confersacquiredresistancetopemetrexedinbreastcancer AT liuyan correctiontohumandrugeffluxtransporterabcc5confersacquiredresistancetopemetrexedinbreastcancer |